BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 4762607)

  • 1. Effects of 6-hydroxydopamine at birth on the development of hypertension in the rat.
    Finch L; Cohen M; Horst WD
    Life Sci; 1973 Nov; 13(10):1403-10. PubMed ID: 4762607
    [No Abstract]   [Full Text] [Related]  

  • 2. Catecholamine uptake sites in the rat heart after 6-hydroxydopamine treatment and in a genetically hypertensive strain.
    Salt PJ; Iversen LL
    Naunyn Schmiedebergs Arch Pharmacol; 1973; 279(4):381-6. PubMed ID: 4273713
    [No Abstract]   [Full Text] [Related]  

  • 3. Onset of hypertension in spontaneously hypertensive rats despite the depletion of spinal cord catecholamines.
    Loewy AD; McKellar S; Swensson EE; Panneton WM
    Brain Res; 1980 Mar; 185(2):449-54. PubMed ID: 7357439
    [No Abstract]   [Full Text] [Related]  

  • 4. Role of saline consumption in the prevention of deoxycorticosterone hypertension in rats by central 6-hydroxydopamine.
    Lewis PJ; Dargie HJ; Dollery CT
    Clin Sci Mol Med; 1975 Apr; 48(4):327-30. PubMed ID: 1126124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of 6-hydroxydopamine on hypertension and noradrenaline content in the brain and heart of spontaneously hypertensive rats].
    Nikodijević O
    Acta Med Iugosl; 1975; 29(3):231-41. PubMed ID: 1146602
    [No Abstract]   [Full Text] [Related]  

  • 6. Cardiovascular changes following DOCA-NaCl or conditioning in 6-hydroxydopamine-treated rats.
    Howard JL; Smith RD; Mueller RA; Breese GR
    Pharmacol Biochem Behav; 1974; 2(4):537-43. PubMed ID: 4153826
    [No Abstract]   [Full Text] [Related]  

  • 7. Adrenaline, noradrenaline and dopamine levels in brain and heart after administration of 6-hydroxydopamine and guanethedine to newborn mice.
    Liuzzi A; Foppen FH; Angeletti PU
    Biochem Pharmacol; 1974 Mar; 23(6):1041-4. PubMed ID: 4824904
    [No Abstract]   [Full Text] [Related]  

  • 8. Long-lasting peripheral and central effects of 6-hydroxydopamine in rats.
    Clark DW; Laverty R; Phelan EL
    Br J Pharmacol; 1972 Feb; 44(2):233-43. PubMed ID: 4677508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of depletion of spinal noradrenaline by 6-hydroxydopamine on the development of renal hypertension in rats.
    Bosland MC; Versteeg DH; van Put J; de Jong W
    Clin Exp Pharmacol Physiol; 1981 Jan; 8(1):67-77. PubMed ID: 7471522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neonatal chemical sympathectomy: functional control of denervation of the vascular system and tissue noradrenaline level in the rat after 6-hydroxydopamine.
    Provoost AP; Bohus B; de Jong W
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 284(4):353-63. PubMed ID: 4375255
    [No Abstract]   [Full Text] [Related]  

  • 11. Neonatal 6-hydroxydopamine treatment: noradrenaline levels and in vitro 3H-catecholamine synthesis in discrete brain regions of adult rats.
    Versteeg DH; van Ree JM; Provoost AP; de Jong W
    Life Sci; 1974 Dec; 15(12):2127-34. PubMed ID: 4621009
    [No Abstract]   [Full Text] [Related]  

  • 12. Proceedings: Effect of 6-hydroxydopamine on neonate spontaneously hypertensive and normotensive rats.
    Ozaki M; Sugawara K; Takami N; Ogawa M; Niwa M
    Jpn Heart J; 1976 May; 17(3):419. PubMed ID: 948140
    [No Abstract]   [Full Text] [Related]  

  • 13. Central catecholamine depletion, vasopressin, and blood pressure in the DOCA/NaCl rat.
    Okuno T; Winternitz SR; Lindheimer MD; Oparil S
    Am J Physiol; 1983 Jun; 244(6):H807-13. PubMed ID: 6407335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of intraventricular and intraspinal 6-hydroxydopamine on blood pressure of DOCA-saline hypertensive rats.
    Kubo T; Hashimoto M
    Arch Int Pharmacodyn Ther; 1979 Mar; 238(1):50-9. PubMed ID: 485704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of central early postnatal 6-hydroxydopamine administration on brain catecholamines and pituitary-adrenal function in adulthood.
    Kaplanski J; Nyakas C; van Delft AM; Smelik PG
    Neuroendocrinology; 1973-1974; 13(1):123-7. PubMed ID: 4779045
    [No Abstract]   [Full Text] [Related]  

  • 16. 6-hydroxydopamine destruction of central adrenergic neurones prevents or reverses developing DOCA-salt hypertension in rats.
    Lamprecht F; Richardson JS; Williams RB; Kopin IJ
    J Neural Transm; 1977; 40(2):149-58. PubMed ID: 323422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between central catecholamine level and post-decapitation convulsion in rats treated with 6-hydroxydopamine.
    Suenaga N; Yamada K; Fukuda T
    Brain Res; 1977 Feb; 122(1):165-9. PubMed ID: 837220
    [No Abstract]   [Full Text] [Related]  

  • 18. Degeneration of central noradrenaline neurons after 6-hydroxydopamine in newborn animals.
    Sachs C; Jonsson G
    Res Commun Chem Pathol Pharmacol; 1972 Jul; 4(1):203-20. PubMed ID: 4671892
    [No Abstract]   [Full Text] [Related]  

  • 19. Studies on the spontaneously hypertensive rat. Genealogy, effects of varying salt intake, and kinetics of catecholamine metabolism.
    Louis WJ; Tabei R; Spector S; Sjoerdsma A
    Circ Res; 1969 May; 24(5):Suppl:93-102. PubMed ID: 5772097
    [No Abstract]   [Full Text] [Related]  

  • 20. Participation of central noradrenergic neurons in experimental hypertension.
    van Ameringen MR; de Champlain J; Imbeault S
    Can J Physiol Pharmacol; 1977 Dec; 55(6):1246-51. PubMed ID: 597776
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.